Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health

Phytotherapy Research

Volumn 21, Issue 2, 2007, Pages 99-112

  Putnam, Sophie E ^a   Scutt, Andy M ^b   Bicknell, Katrina ^a   Priestley, Caroline M ^c   Williamson, Elizabeth M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bone disorders; Diet; Herbal medicines; Nutraceuticals; Osteoporosis

Indexed keywords

ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COMMIPHORA WIGHTII EXTRACT; FLUORIDE; HERBACEOUS AGENT; HORMONE; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SIDA CORDIFOLIA EXTRACT; TERMINALIA ARJUNA EXTRACT; UNCLASSIFIED DRUG; VANDA ROXBURGHII EXTRACT; VITAMIN D DERIVATIVE; WITHANIA SOMNIFERA EXTRACT;

ABDOMINAL PAIN; BONE GROWTH; BONE METABOLISM; BONE REMODELING; CHINESE MEDICINE; CONNECTIVE TISSUE; CONSTIPATION; DIARRHEA; DIET SUPPLEMENTATION; DRUG DOSAGE FORM; DRUG MECHANISM; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; MAINTENANCE THERAPY; METABOLIC BONE DISEASE; NAUSEA; NUTRITIONAL ASSESSMENT; OSTEOBLAST; OSTEOCLAST; OSTEOMALACIA; OSTEOPOROSIS; PEPTIC ULCER; PREVALENCE; REVIEW; RISK FACTOR; SKIN ALLERGY; VOMITING;

ANIMALS; BONE AND BONES; BONE DISEASES, METABOLIC; BONE RESORPTION; COMPLEMENTARY THERAPIES; DIET; DIETARY SUPPLEMENTS; DRUGS, CHINESE HERBAL; HUMANS; OSTEOPOROSIS; PLANTS, MEDICINAL;

ALLIUM CEPA; ALLIUM SATIVUM; PETROSELINUM CRISPUM; RATTUS; ROSMARINUS OFFICINALIS; THYMUS VULGARIS;

EID: 33846996015     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2030     Document Type: Review

References (116)

1. Aggarwal BB, Shishodia S. 2004. Suppression of the nuclear factor-κB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030: 434-441.
2. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walker P. 2002. Molecular Biology of the Cell, 4th edn. Garland: New York.
3. Annie S, Prabhu RG, Malini S. 2006. Activity of Wedelia calendulacea Less, in post-menopausal osteoporosis. Phytomedicine 13: 43-48.
4. Arjmandi BH, Lucas EA, Khalil DA et al. 2005. One year soya protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J 4: 8.
5. Arnett TR, Dempster DW. 1986. Effect of pH on bone resorption by rat osteoclasts in vitro. Endocrinology 119: 119-124.
6. Arnett TR, Dempster DW. 1990. Protons and osteoclasts. J Bone Mineral Res 5: 1099-1103.
7. Bahr JM, Nakai M, Rivera A et al. 2005. Dietary soya protein and isoflavones: minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Menopause 12: 165-173.
8. Berne RM, Levy MN. 1998. Physiology, 4th edn. Mosby Inc.: Philadelphia, USA.
9. Bharti AC, Takada Y, Aggarwal BB. 2004. Curcumin (diferuloylmethane) inhibits RANK ligand-induced Nf-κB activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172: 5940-5947.
10. Bilezikian JP, Rubin MR, Finkelstein JS. 2005. Parathyroid hormone as an anabolic therapy for women and men. J Endocrinol Invest 28 (8 suppl): 41-49.
11. Branca F. 2003. Dietary phyto-oestrogens and bone health. Proc Nutr Soc 62: 877-887.
12. Breitman PL, Fonseca D, Cheung AM, Ward WE. 2003. Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone 33: 597-605.
13. Bruyere O, Edwards J, Reginster JY. 2003. Fracture prevention in postmenopausal women. Clin Evid 10: 1304-1322.
14. Chae HJ, Yun DH, Chin HY et al. 2004. Effect of dang-gui-ji-hwang-yeum on osteoporosis in ovariectomized rats. Am J Chin Med 32: 351-360.
15. Chandanwale AS, Kulkarni KS. 2003. Clinical evaluation of Rumalaya forte in osteoarthrosis. Medicine Update 10(9): 23-26.
16. Chen CH, Ho ML, Chang JK, Hung SH, Wang GJ. 2005a. Green tea catechin enhances osteogenesis in a bone marrow mesenchyrnal stem cell line. Osteoporos Int 16: 2039-2045.
17. Chen H, Emura S, Isono H, Shoumura S. 2005b. Effects of traditional Chinese medicine on bone loss in SAMP6: a murine model for senile osteoporosis. Biol Pharm Bull 28: 865-869.
18. Chen KM, Ge BF, Ma HP, Liu XY, Bai MH, Wang Y. 2005c. lcariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Pharmazie 60: 939-942.
19. Chiba H, Uehara M, Wu J et al. 2003. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133: 1892-1897.
20. Conlisk AJ, Galuska DA. 2000. Is caffeine associated with bone mineral density in young adult women? Prev Med 31: 562-568.
21. Cotter A, Cashman KD. 2003. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 61: 346-351.
22. Das AS, Das D, Mukherjee M, Mukherjee S, Mitra C. 2005. Phytoestrogenic effects of black tea extract (Camellia sinensis) in an oophorectomized rat (Rattus norvegicus) model of osteoporosis. Life Sci 77: 3049-3057.
23. Das AS, Mukherjee M, Mitra C. 2004. Evidence for a prospective anti-osteoporosis effect of black tea (Camilla sinensis) extract in a bilaterally ovariectomized rat model. Asia Pacific J Clin Nutr 13: 210-216.
24. Deyhim F, Stoecker BJ, Brusewitz GH, Devareddy L, Arjmandi BH. 2005. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Menopause 12 (6): 755-762.
25. Devareddy L, Khalil DA, Smith BJ et al. 2006. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone 38: 686-693.
26. Dontas I, Halabalaki M, Moutsatsou P et al. 2006. Protective effect of plant extract from Onobrychis ebenoides on ovariectomy-induced bone loss in rats. Maturitas 53: 234-242.
27. European Commission. 1998. Report on Osteoporosis in the European Community-Action for Prevention. Office for Official Publications of the European Communities: Luxembourg.
28. Fang X, Wu CF, Zhang Y et al. 2005. Increase in bone mass and bone strength by Sambucus williamsii HANCE in ovariectomized rats. Biol Pharm Bull 28: 1879-1885.
29. Ferguson N. 2004. Osteoporosis in Focus. Pharmaceutical Press: London, UK.
30. Fleming A, Masahiko S, Goldsmith P. 2005. High-throughput in vivo screening for bone anabolic compounds with Zebrafish. J Biomol Screen 10: 823-831.
31. Fonseca D, Ward WE. 2004. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35: 489-497.
32. Frassetto LA, Morris RC Jr, Sebastian A. 1996. Effect of age on blood acid-base composition in adult humans: role of age-related renal functional decline. Am J Physiol 271: F1114-F1122.
33. Germano C, Cabot W. 1999. The Osteoporosis Solution: New Therapies for Prevention and Treatment. Kensington Publishing Corp.: NY, USA.
34. Ha H, Ho J, Shin S, Kian H, Koo S, Kim IH, Kim C. Effects of Encommiae Cortex on osteoblast-like cell proliferation and osteoclast inhibition. Arch. Pharm. Res. (2003) 26(11): 929-936.
35. Hegarty VM, Moy HM, Khaw KT. 2000. Tea drinking and bone mineral density in older women. Am J Clin Nutr 71: 1003-1007.
36. Heinrich M, Barnes J, Gibbons S, Williamson EM. 2004. Fundamentals of Pharmacognosy and Phytotherapy. Churchill Livingstone: Edinburgh, UK.
37. Henry BJ. 2001. Clinical Diagnosis and Management by Laboratory Methods, 12th edn. W.B. Saunders company: Philadelphia, USA.
38. Hidaka S, Okamoto Y, Nakajima K, Suekawa M, Liu SY. 1997. Preventive effects of traditional Chinese (Kampo) medicines on experimental osteoporosis induced by ovariectomy in rats. Calcif Tissue Int 61: 239-246.
39. Hidaka S, Okamoto Y, Yamada Y, Kon Y, Kimura T. 1999. A Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats. Phytother Res 13: 14-19.
40. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Rémésy C, Barlet P. 2000. Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 15: 2251-2258.
41. Idris Al, van't Hof RJ, Greig IR et al. 2005. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 11: 774-779.
42. Ishikawa M, Maki K, Kimura K, Kimura M. 2005. Grape seed proanthocyanidins extract promotes bone formation in rat's mandibular condyle. Eur J Oral Sci 113: 47-52.
43. Jeong JC, Lee BT, Yoon CH, Kim HM, Kim CH. 2005. Effects of Drynariae rhizoma on the proliferation of human bone cells and immunomodulatory activity. Pharmacol Res 51: 125-136.
44. Jeong JC, Yoon CH, Jeong CW, Lee YC, Chang YC, Kim CH. 2004. Inhibitory activity of Drynariae rhizoma extracts on cathepsin having bone resorption activity. Immunopharmacol Immunotoxicol 26: 373-385.
45. Joo SS, Won TJ, Kang HC, Lee DI. 2004. Isoflavones extracted from Sophorae fructus upregulate TGF-1 and TGF-beta and inhibit osteoclastogenesis in rat bone marrow cells. Arch Pharmacol Res 27: 99-105.
46. Kamagata-Kiyoura Y, Ohta M, Cheuk G, Yazdani M, Saltzman MJ, Nakamoto T. 1999. Combined effects of caffeine and prostaglandin E2 on the proliferation of osteoblast-like cells (UMR106-01). J Periodontol 70: 283-288.
47. Kanai S, Taniguchi N, Higashino H. 2005. Effect of kami-kihi-to (jia-wei-gui-pi-tang) for experimental osteopenia. Am J Chin Med 33: 41-48.
48. Kanth VR, Diwan PV. 1999. Analgesic, antiinflammatory and hypoglycaemic activities of Sida cordifolia. Phytother Res 3: 75-77.
49. Kassi E, Papoutsi Z, Fokialakis N, Messari I, Mitakou S, Moutsatsou P. 2004. Green plants exhibit selective estrogen receptor modulator (SERM)-like properties. J Argic Food Chem 52: 6956-6961.
50. Khalil DA, Lucas EA, Smith BJ et al. 2005. Soya isoflavones may protect against orchidectomy-induced bone loss in aged male rats. Calcif Tissue Int 76: 56-62.
51. Kim C, Ha H, Lee JH, Kim JS, Song K, Park SW. 2003. Herbal extract prevents bone loss in ovariectomized rats. Arch Pharmacal Res 26: 917-924.
52. Kim J, Um SJ, Woo J et al. 2005. Comparative effect of seeds of Rynchosia volubilis and soyabean on MG-63 human osteoblastic cell proliferation and estrogenicity. Life Sci 78: 30-40.
53. Kim SW, Kim HG, Lee BE, Hwang HH, Baek DH, Ko SY. 2006. Effect of mushroom, Pleurotus eryngii, extracts on bone metabolism. Clin Nutr 25: 166-170.
54. Kumar P, Clark M. 2002. Clinical Medicine, 5th edn. W.B. Saunders company: Edinburgh, UK.
55. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. 1983. Effect of diet on plasma acid-base composition in normal humans. Kidney Int 24: 670-680.
56. Lee SY, Choi DY, Woo ER. 2005. Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza Bunge. Arch Pharmacol Res 28: 909-913.
57. Li X, Cui Q, Kao C, Wang GJ, Balian G. 2003. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPRgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33: 652-659.
58. Liao S, Kao YH, Hiipakka RA. 2001. Green tea: biochemical and biological basis for health benefits. Vitam Horm 62: 1-94.
59. Liggett NW, Reid DM. 2000. The incidence, epidemiology and aetiology of osteoporosis. Hospital Pharmacist 7: 62-68.
60. Lin YP, Zhou RX, Guo SM. Effect of jiangu granule on quality of bone in model rats with osteoporosis induced by ovariectomy. Zhogguo Zhong Xi Yi Jie He Za Zhi (2004) 24(5): 431-4 [Chinese].
61. Liu Y, Zang H, Zhang H, Chen J. 2005. Effect of Herba Epimedii flavone on expression of OPG and RANKL in rat osteoblasts. Zhong Yao Cai 28: 1076-1078.
62. Liu JL, Zhang JY, Chai BF. 1985. Effects of radix Salvia miltiorrhizae on calcium resorption in experimental fracture healing. Zhong Xi Yi Jie He Za Zhi 5: 418.
63. Meng F, Xiong Z, Sun Y, Li F. Coumarins from Cnidium monnieri and their proliferation stimulating activity on osteoblast-like UMR 106 Cells. Pharmazie (2004) 59(8): 643-645.
64. Meng FH, Li YB, Xiong ZL, Jiang ZM, Li FM. 2005. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 12: 189-193.
65. Meselhy MR. 2003. Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents. Phytochemistry 62: 213-218.
66. Miggiano GA, Gagliardi L. 2005. Diet, nutrition and bone health. Clin Ter 156: 47-56.
67. Mingyue W, Ling G, Bei X, Junqing C, Peiqing Z, Jie H. 2005. Clinical observation on 96 cases of primary osteoporosis treated with kidney-tonifying and bone-strengthening mixture. J Tradit Chin Med 25: 132-136.
68. Mori-Okamoto J, Otawara-Hamamoto Y, Yamato H, Yoshimura H. 2004. Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice. J Ethnopharmacol 92: 93-101.
69. Mühlbauer RC. 2001. Rutin cannot explain the effect of vegetables on bone metabolism. J Bone Min Res 16: 970 (letters to the editor).
70. Mühlbauer RC, Li F. 1999. Effect of vegetables on bone metabolism. Nature 401: 343-344.
71. Mühlbauer RC, Lozano A, Palacio S, Reinli A, Felix R. 2003. Common herbs, essential oils and monoterpenes potently modulate bone metabolism. Bone 32: 372-380.
72. Mühlbauer RC, Lozano A, Reinli A. 2002. Onion and a mixture of vegetables, salads and herbs affect bone resorption in the rat by a mechanism independent of their base excess. J Bone Min Res 17: 1230-1236.
73. Mukherjee M, Das AS, Das D, Mukherjee S, Mitra S. 2006a. Role of oil extract of garlic (Allium sativum Linn.) on intestinal transference of calcium and its possible correlation with preservation of skeletal health in an ovariectomized rat model of osteoporosis. Phytother Res 20: 408-415.
74. Mukherjee M, Das AS, Das D, Mukherjee S, Mitra S, Mitra C. 2006b. Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: comparison with the effects of lovastatin and 17β-estradiol. Phytother Res 20: 21-27.
75. Mukherjee M, Das AS, Mitra S, Mitra C. 2004. Prevention of bone loss by oil extract of garlic (Allium sativum Linn.) in an ovariectomized rat model of osteoporosis. Phytother Res 18: 389-394.
76. Nakagawa H, Wachi M, Woo JT et al. 2002. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 292: 94-101.
77. Nayak BS, Suresh R, Rao AV et al. 2005. Evaluation of wound healing activity of Vanda roxburghii R.Br (Orchidacea): a preclinical study in a rat model. Int J Low Extrem Wounds 4: 200-204.
78. New SA. 2003. Intake of fruit and vegetables: implications for bone health. Proc Nutr Soc 62: 889-899.
79. New SA, MacDonald HM, Campbell MK et al. 2004. Lower estimates of net endogenous non-carbonic acid production are positively associated with indexes of bone health in premenopausal and perimenopausal women. Am J Clin Nutr 79: 131-138.
80. New SA, Robins SP, Campbell MK et al. 2000. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health. Am J Clin Nutr 71: 142-151.
81. Nisslein T, Freudenstein J. 2003. Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner Metab 21: 370-376.
82. Ofek O, Karsak M, Leclerc N et al. 2006. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103: 696-701.
83. Ohta M, Cheuk G, Thomas KA et al. 1999. Effects of caffeine on the bones of aged, ovariectomized rats. Ann Nutr Metab 43: 52-59.
84. Puel C, Mathey J, Agalias A et al. 2006. Dose-response study of effect of oleuropein, an olive oil polyphenol, in an ovariectomy/inflammation experimental model of bone loss in the rat. Clin Nutr 25: 859-868.
85. Puel C, Mathey J, Kati-Coulibaly S et al. 2005a. Preventive effect of Abelmoschus manihot (L.) Medik. on bone loss in the ovariectomised rats. J Ethnopharmacol 99: 55-60.
86. Puel C, Quintin A, Agalias A et al. 2004. Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomized rat. Br J Nutr 92: 119-127.
87. Puel C, Quintin A, Mathey J et al. 2005b. Prevention of bone loss by phloridzin, an apple polyphenol, in ovariectomized rats under inflammation conditions. Calcif Tissue Int 77: 311-318.
88. Qian G, Zhang X, Lu L, Wu X, Li S, Meng J. 2006. Regulation of Cbfa 1 expression by total flavonoids of Herba Epimedii. Endocrine J 53: 87-94.
89. Qin L, Zhang G, Hung WY et al. 2005. Phytoestrogen-rich herb 'XLGB' prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats. J Bone Miner Metab 23 (suppl): 55-61.
90. Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Courot G. 2005. Modulation of osteoclastogenesis in porcine bone marrow cultures by quercetin and rutin. Cell Tissue Res 319: 383-393.
91. Reddy NP, Lakshmana M, Udupa UV. 2004. Antiosteoporotic activity of OST-6 (Osteocare), a herbomineral preparation in calcium deficient ovariectomized rats. Phytother Res 18: 25-29.
92. Reginster JY, Sarlet N. 2006. The treatment of severe postmenopausal osteoporosis: a review of current and emerging therapeutic options. Treat Endocrinol 5: 15-23.
93. Remer T, Manz F. 1994. Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nut 59: 1356-1361.
94. Roudsari AHF, Tahbaz Hossein-Nezhad A et al. 2005. Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial. Nutr J 29: 30.
95. Rubin MR, Bilezikian JP. 2005. Parathyroid hormone as an anabolic skeletal therapy. Drugs 65: 2481-2498.
96. Sakamoto S, Sassa S, Kudo H, Suzuki S, Mitamura T, Shinoda H. 2000. Preventive effects of a herbal medicine on bone loss in rats treated with a GnRH agonist. Eur J Endocrinol 143: 139-142.
97. Scutt AM, Williamson EM. 2006. Cannabinoids stimulate fibroblastic-colony formation by bone marrow cells indirectly via CB-2 receptors. Calcif Tissue Int 2006(79) (in press).
98. Shah A, Kolhapure SA. 2004. Evaluation of efficacy and safety of Reosto in senile osteoporosis: A randomized, double-blind placebo-controlled clinical trial. Indian J Clin Practice 15: 25-36.
99. Shirwaikar A, Khan S, Malini S. 2003. Antiosteoporotic effect of ethartol extract of Cissus quadrangularis L. On ovariectomized rat. J Ethnopharmacol 89: 245-250.
100. Shishodia S, Sethi G, Aggarwal BB. 2005. Curcumin: getting back to the roots. Ann N Y Acad Sci 1056: 206-217.
101. Singh RP, Murthy KNC, Jayaorakasha GK. 2002. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extract using in vitro models. J Agric Food Chem 50: 81-86.
102. Stacewicz-Sapuntzakis M, Bowen PE, Hussain EA, Damayanti-Wood BI, Farnsworth NR. 2001. Chemical composition and potential health effects of prunes: a functional food? Crit Rev Food Sci Nutr 41: 251-286.
103. Tanna N. 2005. Osteoporosis and its prevention. Pharm J 275: 521-524.
104. Tassinari MS, Gerstenfeld LC, Stein GS, Lian JB. 1991. Effect of caffeine on parameters of osteoblast growth and differentiation of a mineralized extracellular matrix in vivo. J Bone Miner Res 6: 1029-1036.
105. Tintut Y, Morony S, Demer LL. 2004. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 24(2): 6-10.
106. Tylavsky FA, Holliday K, Danish R, Womack C, Norwood J, Carbone L. 2004. Fruit and vegetable intakes are an independent predictor of bone size in early pubertal children. Am J Clin Nutr 79: 311-317.
107. Wang X, Wu J, Chiba H, Yamada K, Ishimi Y. Paerariae radix prevents bone loss in cashrated male mice. Metabolism (2005) 54(11): 1536-41.
108. Wang D, Li F, Jiang Z. 2001. Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med 67: 748-749.
109. Wasser SP. 2002. Review of medicinal mushrooms advances: good news from old allies. Herbalgram 56: 29-33.
110. Wetli HA, Brenneisen R, Tschudi I et al. 2005. A γ-glutamyl peptide isolated from onion (Allium cepa L.) by bioassay-guided fractionation inhibits resorption activity of osteoclasts. J Agric Food Chem 53: 3408-3414.
111. Wong RWK, Rabie ABM. 2006. Systemic effect of crude extract from Rhizome of Drynaria fortunei on bone formation in mice. Phytother Res 20: 313-315.
112. Xu H, Lawson D. 2004. Effects of Chinese herbal medicine on bone structure and function. J Tradit Chin Med 24: 224-232.
113. Yamaguchi K, Shinohara C, Kojima S, Sodeoka M, Tsuji T. 1999. (2E,6R)-8-Hydroxy-2,6-dimethyl-2-octenoic acid, a novel anti-osteoporotic monoterpene, isolated from Cistanche salsa. Biosci Biotechnol Biochem 63: 731-735.
114. Yin J, Kouda K, Tezuka Y et al. 2004a. New diarylheptanoids from the rhizomes of Dioscorea spongiosa and their antiosteoporotic activity. Planta Med 70: 54-58.
115. Yin J, Tezuka Y, Kouda K et al. 2004b. Antiosteoporotic activity of the water extract of Dioscorea spongiosa. Biol Pharm Bull 27: 583-586.
116. Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS. 2006. Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 29: 291-296.